Style
Aggressive GrowthTurnover
Orientation
Concentrated long-term| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Incyte Corporation(INCY) | 30,762,330 | $3.5B | 17.48% |
| 2 | BeOne Medicines Ltd.(ONC) | 8,801,567 | $2.5B | 12.57% |
| 3 | Revolution Medicines, Inc.(RVMD) | 11,443,357 | $2.1B | 10.74% |
| 4 | Madrigal Pharmaceuticals, Inc.(MDGL) | 2,143,131 | $1.2B | 5.77% |
| 5 | Acadia Pharmaceuticals Inc.(ACAD) | 42,912,904 | $1.1B | 5.44% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 97.94% | 98% | +0.06% |
| Unclassified | 2.06% | 2% | -0.06% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Kymera Therapeutics, Inc.(KYMR) |
| 8,657,242 |
| $992.7M |
| 4.97% |
| 7 | Insmed Incorporated(INSM) | 8,796,111 | $937.8M | 4.70% |
| 8 | Celcuity Inc.(CELC) | 7,915,792 | $828.2M | 4.15% |
| 9 | Kodiak Sciences Inc.(KOD) | 19,919,186 | $776.1M | 3.89% |
| 10 | Rhythm Pharmaceuticals, Inc.(RYTM) | 5,604,483 | $622.3M | 3.12% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 55.37% | 54.51% | -0.86% |
| Mid Cap | 30.92% | 30.81% | -0.11% |
| Small Cap | 11.12% | 11.84% | +0.72% |
| Unclassified | 2.06% | 2% | -0.06% |
| Micro Cap | 0.53% | 0.83% | +0.3% |
Quarter-over-quarter position changes